Based on years cooperation, Vland and Evonik extend the scope to plant, livestock and aquaculture in the solution of probiotics products.
Evonik extends partnership with Chinese biotech company
(GERMANY, 6/28/2019)
Germany-based specialty chemicals company Evonik and Chinese biotech company Vland have signed a Joint Development Agreement (JDA) as part of their existing broader partnership in the field of probiotics for animal nutrition and enzymes for industrial applications.
The new agreement expands deal signed in November 2018.
The combination of Vland’s core production technology and Evonik’s strong global market presence – as well as the shared focus on technology and application of probiotic solutions – is expected to bring mutual benefits to both partners, including new product developments.
![](/attach_fck/vland biotech fis_com.jpg)
Vland specializes in the research and development of four main product categories which are enzymes, probiotics, vaccines and animal health products.
“The JDA is expected to stimulate innovation and joint R&D activities in the field of selection, production, formulation and application of our new probiotic solution,” said Dr. Emmanuel Auer, head of Evonik’s Animal Nutrition Business Line.
“Evonik is excited to partner with Vland in this joint initiative to develop the next probiotic solution focusing on a more sustainable, efficient and environmentally-friendly production,” he added.
![](/attach_fck/evonik campus fis_com.jpg)
The Nutrition & Care segment is led by Evonik Nutrition & Care GmbH and contributes to fulfilling basic human needs. That includes applications for everyday consumer goods as well as animal nutrition and health care. This segment employed about 8,200 employees, and generated sales of around €4.6 billion in 2018.
“Based on years’ cooperation, Vland and Evonik extend the scope to plant, livestock and aquaculture in the solution of probiotics products. After IPO, Vland focus on R&D and globalization, and strive to become a technology-driven enterprise,” said Aron Chen, CEO of Vland.
Vland Biotech was established in 2005 in Qingdao, in the Shandong Province of China. The company specializes in the research and development of four main product categories which are enzymes, probiotics, vaccines and animal health products.
Evonik is one of the world leaders in specialty chemicals. The company says the focus on more specialty businesses, customer-oriented innovative prowess and a trustful and performance-oriented corporate culture form the heart of its corporate strategy.
[email protected]
www.seafood.media
Information of the company:
Address:
|
Rellinghauser Strasse 1-11
|
City:
|
Essen
|
State/ZIP:
|
(D-45128)
|
Country:
|
Germany
|
Phone:
|
+49 201 177-01
|
Fax:
|
+49 201 177-3475
|
More about:
|
|
|